Tomer Israely

3.9k total citations · 3 hit papers
43 papers, 1.6k citations indexed

About

Tomer Israely is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Tomer Israely has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 16 papers in Epidemiology and 14 papers in Virology. Recurrent topics in Tomer Israely's work include SARS-CoV-2 and COVID-19 Research (18 papers), Poxvirus research and outbreaks (14 papers) and Herpesvirus Infections and Treatments (11 papers). Tomer Israely is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (18 papers), Poxvirus research and outbreaks (14 papers) and Herpesvirus Infections and Treatments (11 papers). Tomer Israely collaborates with scholars based in Israel, United States and Croatia. Tomer Israely's co-authors include Nir Paran, Sharon Melamed, Hadas Tamir, Hagit Achdout, Shay Weiss, Yfat Yahalom-Ronen, Ofir Israeli, Noam Erez, Boaz Politi and Adi Beth-Din and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Tomer Israely

43 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The coding capacity of SARS-CoV-2

2020 382 citations Yaara Finkel, Orel Mizrahi et al. Nature profile →
Diagnosis of Imported Monkeypox, Israel, 2018

2019 302 citations Noam Erez, Hagit Achdout et al. Emerging infectious diseases profile →
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

2021 160 citations Yaara Finkel, Aharon Nachshon et al. Nature profile →

Peers

Countries citing papers authored by Tomer Israely

Since Specialization

Citations

This map shows the geographic impact of Tomer Israely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomer Israely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomer Israely more than expected).

Fields of papers citing papers by Tomer Israely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomer Israely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomer Israely. The network helps show where Tomer Israely may publish in the future.

Co-authorship network of co-authors of Tomer Israely

This figure shows the co-authorship network connecting the top 25 collaborators of Tomer Israely. A scholar is included among the top collaborators of Tomer Israely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomer Israely. Tomer Israely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens 2023 ·iScience ·(unknown), (unknown), Hadas Tamir, (unknown), Michael Mor, (unknown), (unknown), David Hagin, Eli Sprecher, Tomer Israely, Natalia T. Freund	28
2	Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system 2023 ·Brain Communications ·Roy Avraham, (unknown), Hagit Achdout, Noam Erez, Ofir Israeli, (unknown), Metsada Pasmanik‐Chor, Nir Paran, Tomer Israely, Einat B. Vitner	6
3	Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic 2023 ·International Journal of Infectious Diseases ·Dani Cohen, Marina Izak, Evgeniy Stoyanov, Michal Mandelboim, (unknown), (unknown), Sophy Goren, Anya Bialik, Limor Kliker, (unknown), (unknown), (unknown), Hadar Marcus, (unknown), Tomer Israely, Nir Paran, Oren Zimhony, Eilat Shinar, ‪Yasmin Maor‬‏, Khitam Muhsen	9
4	VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants 2023 ·Viruses ·Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Hagit Achdout, Noam Erez, Ofir Israeli, Inbar Cohen-Gihon, (unknown), (unknown), Michal Mandelboim, Irit Orr, Ester Feldmesser, Shay Weiss, Adi Beth-Din, Nir Paran, Tomer Israely	2
5	Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice 2022 ·Viruses ·Hila Gutman, Moshe Aftalion, Sharon Melamed, Boaz Politi, Reinat Nevo, (unknown), Hagit Achdout, David Gur, Tomer Israely, Shlomit Dachir, Emanuelle Mamroud, Irit Sagi, Yaron Vagima	11
6	Parsing the role of NSP1 in SARS-CoV-2 infection 2022 ·Cell Reports ·Tal Fisher, (unknown), Krishna Narayanan, Makoto Kuroda, Aharon Nachshon, Jason Hsu, Peter Halfmann, Yfat Yahalom-Ronen, Hadas Tamir, Yaara Finkel, Michal Schwartz, Shay Weiss, Chien‐Te K. Tseng, Tomer Israely, Nir Paran, Yoshihiro Kawaoka, Shinji Makino, (unknown)	43
7	Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 2022 ·Nature Communications ·Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Shahar Rotem, Uri Elia, Ital Nemet, Limor Kliker, Michal Mandelboim, Adi Beth-Din, Tomer Israely, Ofer Cohen, Noam Stern‐Ginossar, Adi Bercovich-Kinori	29
8	SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis breakdown → 2021 ·Nature ·Yaara Finkel, (unknown), Aharon Nachshon, Roni Winkler, Tal Fisher, Batsheva Rozman, Orel Mizrahi, Yoav Lubelsky, B. M. Zuckerman, Boris Slobodin, Yfat Yahalom-Ronen, Hadas Tamir, Igor Ulitsky, Tomer Israely, Nir Paran, Michal Schwartz, Noam Stern‐Ginossar	160
9	Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus 2021 ·Journal of Biological Chemistry ·Einat B. Vitner, Hagit Achdout, Roy Avraham, Boaz Politi, Lilach Cherry, Hadas Tamir, Yfat Yahalom-Ronen, Nir Paran, Sharon Melamed, Noam Erez, Tomer Israely	29
10	Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity 2021 ·Nature Communications ·Hagit Achdout, Einat B. Vitner, Boaz Politi, Sharon Melamed, Yfat Yahalom-Ronen, Hadas Tamir, Noam Erez, Roy Avraham, Shay Weiss, Lilach Cherry, Erez Bar‐Haim, Efi Makdasi, David Gur, Moshe Aftalion, Theodor Chitlaru, Yaron Vagima, Nir Paran, Tomer Israely	50
11	SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection 2021 ·PLoS Pathogens ·(unknown), Hagit Achdout, (unknown), Orit Berhani, (unknown), Einat B. Vitner, Sharon Melamed, Boaz Politi, Eran Zahavy, Ilija Brizić, T. Rovis, (unknown), Dana G. Wolf, Stipan Jonjić, Tomer Israely, Ofer Mandelboim	17
12	The coding capacity of SARS-CoV-2 breakdown → 2020 ·Nature ·Yaara Finkel, Orel Mizrahi, Aharon Nachshon, Shira Weingarten-Gabbay, David Morgenstern, Yfat Yahalom-Ronen, Hadas Tamir, Hagit Achdout, Dana Stein, Ofir Israeli, Adi Beth-Din, Sharon Melamed, Shay Weiss, Tomer Israely, Nir Paran, Michal Schwartz, Noam Stern‐Ginossar	382
13	Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments 2020 ·Scientific Reports ·Yaron Vagima, David Gur, Noam Erez, Hagit Achdout, Moshe Aftalion, Yinon Levy, Ayelet Zauberman, Avital Tidhar, Hila Gutman, Shlomi Lazar, Tomer Israely, Nir Paran, Sharon Melamed, Tal Brosh‐Nissimov, Theodor Chitlaru, Irit Sagi, Emanuelle Mamroud	4
14	Diagnosis of Imported Monkeypox, Israel, 2018 breakdown → 2019 ·Emerging infectious diseases ·Noam Erez, Hagit Achdout, Elad Milrot, Yuval Schwartz, Yonit Wiener‐Well, Nir Paran, Boaz Politi, Hadas Tamir, Tomer Israely, Shay Weiss, Adi Beth-Din, Ohad Shifman, Ofir Israeli, Shmuel Yitzhaki, Shmuel C. Shapira, Sharon Melamed, Eli Schwartz	302
15	Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models 2017 ·Vaccine ·Hagit Achdout, Shlomo Lustig, Tomer Israely, Noam Erez, Boaz Politi, Hadas Tamir, Ofir Israeli, Trevor Waner, Sharon Melamed, Nir Paran	9
16	TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines 2014 ·PLoS ONE ·Tomer Israely, Sharon Melamed, Hagit Achdout, Noam Erez, Boaz Politi, Trevor Waner, Shlomo Lustig, Nir Paran	15
17	Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response 2013 ·Virology Journal ·Nir Paran, Shlomo Lustig, Anat Zvi, Noam Erez, Tomer Israely, Sharon Melamed, Boaz Politi, D. Ben‐Nathan, Paula A. Schneider, Bat‐El Lachmi, Ofir Israeli, Dana Stein, (unknown), Udy Olshevsky	27
18	A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease 2012 ·Virology Journal ·Tomer Israely, Nir Paran, Shlomo Lustig, Noam Erez, Boaz Politi, Avigdor Shafferman, Sharon Melamed	18
19	Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response 2009 ·Vaccine ·Shlomo Lustig, Galia Maik-Rachline, Nir Paran, Sharon Melamed, Tomer Israely, Noam Erez, Nadav Orr, Shaul Reuveny, Arie Ordentlich, Orgad Laub, Avigdor Shafferman, Baruch Velan	29
20	Role of endosymbiotic zooxanthellae and coral mucus in the adhesion of the coral-bleaching pathogen Vibrio shiloi to its host 2001 ·FEMS Microbiology Letters ·Ehud Banin, Tomer Israely, Maoz Fine, Yossi Loya, Eugene Rosenberg	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact